SummaryDopamine contributes to corticostriatal plasticity and motor learning. Dopamine denervation profoundly alters motor performance, as in Parkinson’s disease (PD); however, the extent to which these symptoms reflect impaired motor learning is unknown. Here, we demonstrate a D2 receptor blockade-induced aberrant learning that impedes future motor performance when dopamine signaling is restored, an effect diminished by coadministration of adenosine antagonists during blockade. We hypothesize that an inappropriate corticostriatal potentiation in striatopallidal cells of the indirect pathway underlies aberrant learning. We demonstrate synaptic potentiation in striatopallidal neurons induced by D2 blockade and diminished by application of an...
The loss of dopamine (DA) in Parkinson’s is accompanied by the emergence of exaggerated theta and be...
Degeneration of dopaminergic neurons leads to Parkinson's disease (PD), characterized by reduced lev...
Abstract Adenosine A 2A antagonists can exert antiparkinsonian effects in animal models. Recent expe...
SummaryDopamine contributes to corticostriatal plasticity and motor learning. Dopamine denervation p...
Dopamine contributes to corticostriatal plasticity and motor learning. Dopamine denervation profound...
Parkinson's disease (PD) is a neurodegenerative disorder characterized by a progressive decline in m...
Motor dysfunction in Parkinson’s disease is believed to arise primarily from pathophysiol-ogy in the...
The long-lasting deterioration of motor output in Parkinson’s disease (PD) is thought to arise from ...
About a half a century has passed since dopamine was identified as a neurotransmitter, and it has be...
Abnormal involuntary movements (AIMs) and dyskinesias elicited by drugs that stimulate dopamine rece...
The role dopamine plays in decision-making has important theoretical, empirical and clinical implica...
Motor dysfunction in Parkinson’s disease is believed to arise primarily from pathophysiology in the ...
Parkinson's disease (PD) is a neurodegenerative disorder characterised by typicalmotor symptoms that...
Wepresent a neural network model of cognition in medicated and unmedicated patients with Parkinson’s...
Emerging evidence suggests that dopamine may modulate learning and memory with important implication...
The loss of dopamine (DA) in Parkinson’s is accompanied by the emergence of exaggerated theta and be...
Degeneration of dopaminergic neurons leads to Parkinson's disease (PD), characterized by reduced lev...
Abstract Adenosine A 2A antagonists can exert antiparkinsonian effects in animal models. Recent expe...
SummaryDopamine contributes to corticostriatal plasticity and motor learning. Dopamine denervation p...
Dopamine contributes to corticostriatal plasticity and motor learning. Dopamine denervation profound...
Parkinson's disease (PD) is a neurodegenerative disorder characterized by a progressive decline in m...
Motor dysfunction in Parkinson’s disease is believed to arise primarily from pathophysiol-ogy in the...
The long-lasting deterioration of motor output in Parkinson’s disease (PD) is thought to arise from ...
About a half a century has passed since dopamine was identified as a neurotransmitter, and it has be...
Abnormal involuntary movements (AIMs) and dyskinesias elicited by drugs that stimulate dopamine rece...
The role dopamine plays in decision-making has important theoretical, empirical and clinical implica...
Motor dysfunction in Parkinson’s disease is believed to arise primarily from pathophysiology in the ...
Parkinson's disease (PD) is a neurodegenerative disorder characterised by typicalmotor symptoms that...
Wepresent a neural network model of cognition in medicated and unmedicated patients with Parkinson’s...
Emerging evidence suggests that dopamine may modulate learning and memory with important implication...
The loss of dopamine (DA) in Parkinson’s is accompanied by the emergence of exaggerated theta and be...
Degeneration of dopaminergic neurons leads to Parkinson's disease (PD), characterized by reduced lev...
Abstract Adenosine A 2A antagonists can exert antiparkinsonian effects in animal models. Recent expe...